Clinical significance of HER2 overexpression as assessed by immunohistochemistry and fluorescence in situ hybridisation in patients with gastric cancer

被引：0
|
作者：
Im, S. [1 ]
Kim, J. [1 ]
Kim, M. [1 ]
Jordan, B. [2 ]
Oh, D. [1 ]
Lee, H. [1 ]
Yang, H. [1 ]
Kim, V [1 ]
Kim, W. [1 ]
Bang, Y. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea
[2] Roche Diagnost Ltd, Rotkreuz, Switzerland
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [21] Discrepancy Between HER2 Immunohistochemistry and Fluorescence In Situ Hybridization in Esophageal and Gastric Adenocarcinoma
    Huh, Won Jae
    Sanders, Melinda
    Charoenpitakchai, Mongkon
    Salaria, Safia
    Washington, Mary
    Shi, Chanjuan
    LABORATORY INVESTIGATION, 2015, 95 : 165A - 166A
  • [22] Discrepancy Between HER2 Immunohistochemistry and Fluorescence In Situ Hybridization in Esophageal and Gastric Adenocarcinoma
    Huh, Won Jae
    Sanders, Melinda
    Charoenpitakchai, Mongkon
    Salaria, Sofia
    Washington, Mary
    Shi, Chanjuan
    MODERN PATHOLOGY, 2015, 28 : 165A - 166A
  • [23] Clinicopathologic Characteristics of Patients With Stage III/IV (M0) Advanced Gastric Cancer, According to HER2 Status Assessed by Immunohistochemistry and Fluorescence In Situ Hybridization
    Im, Seock-Ah
    Kim, Jin Won
    Kim, Jin-Soo
    Kim, Min A.
    Jordan, Bruce
    Pickl, Marlene
    Han, Sae-Won
    Oh, Do-Youn
    Lee, Hyuk Joon
    Kim, Tae-You
    Kim, Woo Ho
    Yang, Han-Kwang
    Bang, Yung-Jue
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2011, 20 (02) : 94 - 100
  • [24] Prognosis significance of HER2/neu overexpression and amplification in patients with curatively resected gastric cancer
    Zhou, Fei
    Li, Ning
    Hua, Zhaolai
    Xia, Lin
    Wang, Liwei
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Clinical significance of intratumoral HER2 heterogeneity in gastric cancer
    Lee, Hee Eun
    Park, Kyoung Un
    Yoo, Seol Bong
    Nam, Soo Kyung
    Park, Do Joong
    Kim, Hyung-Ho
    Lee, Hye Seung
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1448 - 1457
  • [26] Comparison of Chromogenic in Situ Hybridisation (CISH) with Immunohistochemistry (IHC) for the Detection of HER2 Status in Breast Cancer
    Desai, S.
    Shirsat, H.
    Epari, S.
    Bagal, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 659 - 660
  • [27] Predicting HER2 status of breast cancer from basic pathology features: HER2 status of 1500 breast cancers determined by immunohistochemistry and fluorescence in situ hybridisation with pathology correlation
    Bilous, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S52 - S52
  • [28] Comparison of fluorescence in situ hybridization (FISH) with immunohistochemistry (IHC) for detection of HER2/neu amplification/overexpression in breast cancer.
    Sun, G
    Morales, JS
    Wilz, S
    McKee, C
    Amberson, J
    Gersen, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 107 - 107
  • [29] Clinical Significance and HER2 Expression of Circulating Tumor Cells in Patients with Gastric Cancer
    Uenosono, Y.
    Arigami, T.
    Yanagita, S.
    Matsushita, D.
    Haraguchi, N.
    Hagihara, T.
    Kozono, T.
    Ishigami, S.
    Natsugoe, S.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S36 - S37
  • [30] Overexpression of HER2/neu in gastric cancer in South African patients
    Swart, P. J.
    Le Roux, G.
    Myburg, M.
    Beukes, C. A.
    Goedhals, J.
    HISTOPATHOLOGY, 2010, 57 : 93 - 94
12345